Refractory Non-Hodgkin's lymphoma Completed Phase 1 / 2 Trials for Etoposide (DB00773)

Also known as: Refractory Non Hodgkin Lymphoma / Refractory Non-Hodgkin Lymphoma / Refractory Non-Hodgkin Lympoma / Refractory Non-Hodgkin-Lymphoma / Non-Hodgkin's lymphoma refractory / Non-Hodgkin's lymphoma NOS refractory

IndicationStatusPhase
DBCOND0024997 (Refractory Non-Hodgkin's lymphoma)Completed1 / 2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00005803Autologous Stem Cell Transplant Followed by Donor Stem Cell Transplant in Treating Patients With Relapsed or Refractory LymphomaTreatment